Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
AT7867
Cat No.
CEI-0110
Description
As an ATP-competitive inhibitor, AT7867 can potently Akt1, Akt2, Akt3 and S6K with IC50 of 32 nM, 17 nM, 47 nM and 85 nM.
CAS No.
857531-00-1
Molecular Weight
337.85
Purity
>99%
Storage
2 years at -20 centigrade
Targets
Akt1, Akt2, Akt3, S6K
Molecular Formula
C20H20ClN3
Chemical Name
4-(4-(1H-pyrazol-4-yl)phenyl)-4-(4-chlorophenyl)piperidine
Solubility
DSMO 68 mg/mL Water
In vitro
As an ATP-competitive small molecule inhibitor, AT7867 can potently inhibitor of Akt, p70S6 kinase and PKA. AT7867 can also blocked proliferation in a number of human cancer cell lines which exhibit deregulation of the PI3K/AKT pathway by mechanisms, such as PTEN or PIK3CA mutations. In addition, the MES-SA uterine cell line seemed to be the most sensitive to growth inhibition by AT7867.
In vivo
In MES-SA tumor xenografts, doses of AT7867 (90 mg/kg p.o. or 20 mg/kg i.p.) were given to athymic mice bearing MES-SA tumors. Clear inhibition of phosphorylation of GSK3betaand S6RP in tumors was seen at 2 and 6 hours following treatment with AT7867 and AT7867 can induce an increase in cleaved PARP, leading to inducing apoptosis in the xenograft tumor cells.
Download
Download Datasheet